Skip to main content

Month: April 2020

Gaumont : Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 mars 2020

GAUMONTInformations relatives au nombre total de droits de vote et d’actions du capital socialprévues par l’article L. 233-8-II du code de commerceet l’article 223-16 du règlement général de l’Autorité des marchés financiersLe 8 avril 2020Gaumont est une société cotée sur Euronext Paris – Eurolist Compartiment B – Code ISIN FR0000034894 – www.gaumont.frPièce jointeversion pdf

Continue reading

Gildan Activewear to start producing personal protective equipment to help slow the spread of COVID-19

MONTREAL, April 08, 2020 (GLOBE NEWSWIRE) — Gildan Activewear Inc. (GIL: TSX and NYSE) today announced that it has joined forces with various business partners to leverage its manufacturing facilities to produce non-medical face masks and isolation gowns in support of the global fight against the COVID-19 pandemic.Gildan is working with one of its customers in the imprintables channel to support a cooperative consortium of major apparel and textile companies to help produce non-medical face masks to be distributed to support hospitals, health care workers and others battling the spread of the COVID-19 virus. Both the design and textile fabric to be used in the production of these masks are being provided by partners of the consortium who are working in collaboration to lessen the major shortage of face masks. Gildan is also working...

Continue reading

Les Vêtements de Sport Gildan Inc commencera à produire de l’équipement de protection individuelle pour aider à ralentir la propagation de la COVID-19

MONTRÉAL, 08 avr. 2020 (GLOBE NEWSWIRE) — Les Vêtements de Sport Gildan Inc. (TSX et NYSE : GIL) a annoncé aujourd’hui qu’elle s’est associée à divers partenaires commerciaux pour tirer parti de ses installations de fabrication afin de produire des masques faciaux non médicaux et des tenues d’hôpital pour soutenir la lutte mondiale contre la pandémie de la COVID-19.Gildan travaille avec l’un de ses clients du réseau des vêtements à imprimer pour soutenir un consortium coopératif de grandes entreprises de vêtements et de textiles afin de contribuer à la production de masques faciaux non médicaux qui seront distribués pour soutenir les hôpitaux, les travailleurs de la santé et d’autres personnes luttant contre la propagation du virus de la COVID-19. La conception et le tissu utilisés pour la production...

Continue reading

UPDATE — Emerging Markets Report – Biotricity’s Bioflux RMT a Tool to Identify Life Threating QT Prolongation In COVID-19 Patients

ORLANDO, Fla., April 08, 2020 (GLOBE NEWSWIRE) — As government and private institutions race to develop an effective cure for patients infected by COVID-19, two antimalarial drugs–chloroquine and hydroxychloroquine–have shown some possible potential. Under an emergency use authorization (“EUA”), the FDA has authorized these antimalarial drugs to be distributed and prescribed by doctors to COVID-19 patients, as appropriate, when a clinical trial is not available or feasible.  Though both drugs are still in their testing phases.Chloroquine and hydroxychloroquine pose cardiac risks. And so managing those risks during the treatment process is key to the successful implementation. In a recent press release, Biotricity (OTC: BTCY), a medical diagnostic and consumer healthcare technology company, announced that its premier...

Continue reading

Berry Corporation (bry) To Report First Quarter 2020 Results May 6; Hold Conference Call May 7

DALLAS, April 08, 2020 (GLOBE NEWSWIRE) — Berry Corporation (bry) (NASDAQ:BRY) (“Berry”) today announced it will report its first quarter 2020 financial results on Wednesday, May 6, 2020 after the close of U.S financial markets. Berry will host a conference call on Thursday, May 7, 2020 to discuss these results:A live audio webcast will be available on the “Events” section of Berry’s website at bry.com/category/events. An audio replay will be available shortly after the broadcast:A replay of the audio webcast will also be archived on the “Events” section of Berry’s website at bry.com/category/events.About BerryBerry is a publicly traded (NASDAQ:BRY) western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. More information can be found...

Continue reading

Capgemini successfully prices a €3.5 billion bond issue

This press release may not be distributed directly or indirectlyin the United States, Canada, Australia or JapanInvestor Relations:Vincent BiraudTel: +33 (0)1 47 54 50 87Email: vincent.biraud@capgemini.comCapgemini successfully prices a €3.5 billion bond issueParis, 8 April 2020 – Capgemini announces that it successfully priced on April 8, 2020, a total of €3.5 billion bonds comprising four tranches:€500 million 2-year notes (the 2022 tranche), with a coupon of 1.250% (issue price 99.794%),€800 million 6-year notes (the 2026 tranche), with a coupon of 1.625% (issue price 99.412%),€1 billion 9-year notes (the 2029 tranche), with a coupon of 2.000% (issue price 99.163%) and€1.2 billion 12-year notes (the 2032 tranche), with a coupon of 2.375% (issue price 99.003%).This bond offering was a great success with an oversubscription of...

Continue reading

Capgemini place avec succès une émission obligataire de 3,5 milliards €

Ce communiqué ne peut être distribué directement ou indirectementaux Etats-Unis, Canada, Australie ou JaponRelations Investisseurs :Vincent BiraudTél. : 01 47 54 50 87Email: vincent.biraud@capgemini.comCapgemini place avec succès une émission obligataire de 3,5 milliards €Paris, le 8 avril 2020 – Capgemini annonce avoir fixé avec succès le 8 avril 2020 les conditions d’un emprunt obligataire de 3,5 milliards d’euros comprenant quatre tranches :500 millions d’euros à 2 ans (la tranche 2022), portant un coupon de 1,250% (prix d’émission 99,794%),800 millions d’euros à 6 ans (la tranche 2026), portant un coupon de 1,625% (prix d’émission 99,412%),1 milliard d’euros à 9 ans (la tranche 2029), portant un coupon de 2,000% (prix d’émission 99,163%) et1,2 milliard d’euros à 12 ans (la tranche 2032), portant un coupon de...

Continue reading

1st Capital Bank Announces Executive Team Appointments

SALINAS, Calif., April 08, 2020 (GLOBE NEWSWIRE) — The Board of Directors of 1st Capital Bank (OTC Pink: FISB) today announced changes to its executive team to further its mission to serve the business community along California’s Central Coast.  Samuel D. Jimenez has been named chief executive officer, and Jon D. Ditlevsen, the Bank’s executive vice president and chief lending officer since 2013, will assume the role of president.Jimenez brings to the bank nearly thirty years of banking experience, including six years as chief operating officer of Bank of Commerce Holdings, Sacramento, California. His background also includes service as chief financial officer and director of risk management in a community bank setting, as well as eleven years as a Federal Deposit Insurance Corporation examiner. Jimenez will be responsible for...

Continue reading

Akerna Acquires Cultivation Compliance Software Company Trellis

DENVER, April 08, 2020 (GLOBE NEWSWIRE) — Akerna (Nasdaq: KERN), a leading compliance technology provider and developer of the cannabis industry’s first seed-to-sale enterprise resource planning (ERP) software technology (MJ Platform®), will acquire cannabis cultivation management and compliance software company Trellis for $2.0 million in an all-stock deal.  The deal is expected to close later this week.“Trellis has built a great product that has attracted an impressive list of well-known California operators,” said Jessica Billingsley, CEO, Akerna.  “We’re excited to be able to plug Trellis into our compliance bus, leverage our infrastructure, and profitably take Trellis into new markets where Akerna has an established presence. Trellis is an ideal fit for Akerna and delivers immediate accretive value to our shareholders.” The...

Continue reading

Basilea shareholders approve all proposals of the Board of Directors at the Annual General Meeting

Basel, Switzerland, April 08, 2020Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that shareholders approved all proposals of the Board of Directors at today’s Annual General Meeting (AGM) for the financial year 2019.In accordance with the COVID-19 Ordinance 2 issued by the Swiss Federal Council, it was not permitted to have physical participation of shareholders at the AGM. Basilea had already recommended on March 20 that shareholders should delegate their votes to the Independent Proxy. At the AGM, the Independent Proxy represented 26.2 percent of the total voting rights. Currently, 58.8 percent of the total shares outstanding are registered in Basilea’s share registry.Domenico Scala, Basilea’s Chairman of the Board commented: “We thank our shareholders for the broad support of the proposed motions. While the coronavirus...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.